- Home
- LEE vs APYX Comparison
LEE vs APYX Comparison
Compare LEE & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEE
- APYX
- Stock Information
- Founded
- LEE 1890
- APYX 1982
- Country
- LEE United States
- APYX United States
- Employees
- LEE N/A
- APYX N/A
- Industry
- LEE Newspapers/Magazines
- APYX Medical/Dental Instruments
- Sector
- LEE Consumer Discretionary
- APYX Health Care
- Exchange
- LEE Nasdaq
- APYX Nasdaq
- Market Cap
- LEE N/A
- APYX 42.3M
- IPO Year
- LEE N/A
- APYX 1987
- Fundamental
- Price
- LEE $15.15
- APYX $1.57
- Analyst Decision
- LEE
- APYX Hold
- Analyst Count
- LEE 0
- APYX 2
- Target Price
- LEE N/A
- APYX N/A
- AVG Volume (30 Days)
- LEE 25.5K
- APYX 68.8K
- Earning Date
- LEE 12-12-2024
- APYX 11-08-2024
- Dividend Yield
- LEE N/A
- APYX N/A
- EPS Growth
- LEE N/A
- APYX N/A
- EPS
- LEE N/A
- APYX N/A
- Revenue
- LEE $611,380,000.00
- APYX $48,542,000.00
- Revenue This Year
- LEE $2.04
- APYX N/A
- Revenue Next Year
- LEE N/A
- APYX $2.78
- P/E Ratio
- LEE N/A
- APYX N/A
- Revenue Growth
- LEE N/A
- APYX N/A
- 52 Week Low
- LEE $7.56
- APYX $0.97
- 52 Week High
- LEE $19.63
- APYX $2.80
- Technical
- Relative Strength Index (RSI)
- LEE 41.55
- APYX 50.85
- Support Level
- LEE $14.52
- APYX $1.46
- Resistance Level
- LEE $15.99
- APYX $1.72
- Average True Range (ATR)
- LEE 1.04
- APYX 0.20
- MACD
- LEE -0.21
- APYX -0.03
- Stochastic Oscillator
- LEE 41.21
- APYX 30.91
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.